Does ADALIMUMAB-AATY Cause Disease recurrence? 6 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Disease recurrence have been filed in association with ADALIMUMAB-AATY (Yuflyma). This represents 0.4% of all adverse event reports for ADALIMUMAB-AATY.
6
Reports of Disease recurrence with ADALIMUMAB-AATY
0.4%
of all ADALIMUMAB-AATY reports
0
Deaths
3
Hospitalizations
How Dangerous Is Disease recurrence From ADALIMUMAB-AATY?
Of the 6 reports, 3 (50.0%) required hospitalization.
Is Disease recurrence Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ADALIMUMAB-AATY. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does ADALIMUMAB-AATY Cause?
Intentional dose omission (338)
Drug ineffective (151)
Intentional product use issue (151)
Death (132)
Arthralgia (96)
Rheumatoid arthritis (94)
Fatigue (92)
Therapy interrupted (88)
Crohn's disease (87)
Headache (86)
What Other Drugs Cause Disease recurrence?
NIRMATRELVIR\RITONAVIR (20,040)
PREDNISONE (1,979)
CYCLOPHOSPHAMIDE (1,689)
RITUXIMAB (1,588)
METHOTREXATE (1,401)
DOXORUBICIN (980)
VINCRISTINE (932)
PREDNISOLONE (873)
MYCOPHENOLATE MOFETIL (852)
DEXAMETHASONE (784)
Which ADALIMUMAB-AATY Alternatives Have Lower Disease recurrence Risk?
ADALIMUMAB-AATY vs ADALIMUMAB-ADAZ
ADALIMUMAB-AATY vs ADALIMUMAB-ADBM
ADALIMUMAB-AATY vs ADALIMUMAB-AFZB
ADALIMUMAB-AATY vs ADALIMUMAB-ATTO
ADALIMUMAB-AATY vs ADALIMUMAB-BWWD